About the folio

Why Texas?

Semaglutide Texas is an editorial title. There is no Texas treatment operation behind it, and the name supplies no evidence about local care. This is a research site, with no medical business, prescribing service or booking desk.

Texas suggests a wide view to me: room to notice the distance between a striking early result and an answer that lasts. That is the attraction of the name. I like a large finding, then feel a strong urge to ask how it looks farther down the road. The horizon is an image; any claim about semaglutide has to stand on the published research.

What earns my interest

I value a study that lets an effect acquire some history. The 104-week STEP 5 result interests me for its duration. The cardiovascular endpoint in SELECT matters to me for moving the subject from weight to serious health events.

I also have room for an unfinished question. The small alcohol-use-disorder trial is an example: an interesting human experiment whose short observation period makes me hungry for follow-up. I can be curious about it without pretending its reach matches the larger outcome studies.

Where the folio ends

These pages contain my judgments about published research. They cannot assess a person's health or decide whether a medicine fits their circumstances. Nothing here is medical advice, and no treatment decision can be made through this site.

I have no personal treatment account to offer. The people in the illustrations are imagined figures, with no claim to represent the writer or anyone in a trial. Likewise, the landscape is a visual idea for distance, with no claim that the studies took place there.

The reading list gathers the sources discussed here. The contact page explains the present limits on sending a correction. Faced with a precise correction to a study population or outcome, I'd happily sacrifice a tidy argument.